DE602007008882D1 - Neuer kristall von 3-ä5-ä4-(cyclopentyloxy)-2-hydroxybenzoylü-2-ä(3-hydroxy-1,2-benzisoxazol-6-yl)methoxyüphenylüpropionsäure - Google Patents

Neuer kristall von 3-ä5-ä4-(cyclopentyloxy)-2-hydroxybenzoylü-2-ä(3-hydroxy-1,2-benzisoxazol-6-yl)methoxyüphenylüpropionsäure

Info

Publication number
DE602007008882D1
DE602007008882D1 DE602007008882T DE602007008882T DE602007008882D1 DE 602007008882 D1 DE602007008882 D1 DE 602007008882D1 DE 602007008882 T DE602007008882 T DE 602007008882T DE 602007008882 T DE602007008882 T DE 602007008882T DE 602007008882 D1 DE602007008882 D1 DE 602007008882D1
Authority
DE
Germany
Prior art keywords
cyclopentyloxy
hydroxy
hydroxybenzoylü
benzisoxazole
new crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008882T
Other languages
English (en)
Inventor
Kenji Yonezawa
Hironori Kotsubo
Yasutaka Baba
Yukie Tada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of DE602007008882D1 publication Critical patent/DE602007008882D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE602007008882T 2006-05-26 2007-05-25 Neuer kristall von 3-ä5-ä4-(cyclopentyloxy)-2-hydroxybenzoylü-2-ä(3-hydroxy-1,2-benzisoxazol-6-yl)methoxyüphenylüpropionsäure Active DE602007008882D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006146220 2006-05-26
PCT/JP2007/060670 WO2007138996A1 (ja) 2006-05-26 2007-05-25 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸の新規な結晶

Publications (1)

Publication Number Publication Date
DE602007008882D1 true DE602007008882D1 (de) 2010-10-14

Family

ID=38778516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008882T Active DE602007008882D1 (de) 2006-05-26 2007-05-25 Neuer kristall von 3-ä5-ä4-(cyclopentyloxy)-2-hydroxybenzoylü-2-ä(3-hydroxy-1,2-benzisoxazol-6-yl)methoxyüphenylüpropionsäure

Country Status (27)

Country Link
US (1) US7977492B2 (de)
EP (1) EP2022788B1 (de)
JP (1) JP5117381B2 (de)
KR (1) KR101389038B1 (de)
CN (1) CN101454298B (de)
AT (1) ATE479666T1 (de)
AU (1) AU2007268771B2 (de)
BR (1) BRPI0712909A2 (de)
CA (1) CA2652939C (de)
CY (1) CY1111398T1 (de)
DE (1) DE602007008882D1 (de)
DK (1) DK2022788T3 (de)
EC (1) ECSP089000A (de)
ES (1) ES2351065T3 (de)
HR (1) HRP20100544T1 (de)
IL (1) IL195416A (de)
MA (1) MA30510B1 (de)
MX (1) MX2008014906A (de)
NO (1) NO20084632L (de)
NZ (1) NZ573034A (de)
PL (1) PL2022788T3 (de)
PT (1) PT2022788E (de)
RS (1) RS51517B (de)
RU (1) RU2429233C2 (de)
SI (1) SI2022788T1 (de)
WO (1) WO2007138996A1 (de)
ZA (1) ZA200809922B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1988085E (pt) * 2006-02-21 2015-02-05 Toyama Chemical Co Ltd Processo para a produção de éster de propionato de 3-[5-[4-(ciclopentiloxi)-2-hidroxibenzoil]-2-[(3- hidroxi-1,2-benzisoxazol-6-il)metoxi]fenilo] e produtos intermédios para o processo
PT2258361E (pt) * 2008-03-27 2014-10-15 Toyama Chemical Co Ltd Utilização de uma combinação de um derivado de benzofenona ou de um seu sal com um inibidor de tnfalfa e composição farmacêutica contendo o referido sal ou derivado e o inibidor
KR101525851B1 (ko) 2008-04-22 2015-06-04 토야마 케미칼 컴퍼니 리미티드 벤조페논 유도체 또는 그 염 및 면역억제제를 조합하여 사용하는 방법 및 이들을 함유하는 의약조성물
CN103183647B (zh) * 2011-12-28 2017-06-09 天津市国际生物医药联合研究院有限公司 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042150A (en) 1960-01-26 1962-07-03 Lukawsky Michael Emergency brake and anti-skid device
US5637585A (en) * 1993-07-06 1997-06-10 Yamanouchi Pharmaceutical Co., Ltd. Crystal form of benzodiazepine derivatives
CN100378063C (zh) * 1998-11-05 2008-04-02 富山化学工业株式会社 新型化合物及其医药用途
JP4976617B2 (ja) * 2000-03-17 2012-07-18 富山化学工業株式会社 新規なベンゾフェノン誘導体およびその塩
KR100947253B1 (ko) 2001-11-16 2010-03-11 토야마 케미칼 컴퍼니 리미티드 신규의 벤조페논유도체 또는 그 염

Also Published As

Publication number Publication date
MA30510B1 (fr) 2009-06-01
EP2022788A1 (de) 2009-02-11
WO2007138996A1 (ja) 2007-12-06
EP2022788B1 (de) 2010-09-01
JPWO2007138996A1 (ja) 2009-10-08
HRP20100544T1 (hr) 2010-11-30
CA2652939A1 (en) 2007-12-06
BRPI0712909A2 (pt) 2012-10-02
JP5117381B2 (ja) 2013-01-16
ECSP089000A (es) 2009-02-27
EP2022788A4 (de) 2009-06-24
SI2022788T1 (sl) 2011-01-31
CN101454298B (zh) 2011-11-16
MX2008014906A (es) 2008-12-09
ZA200809922B (en) 2010-02-24
KR20090014194A (ko) 2009-02-06
KR101389038B1 (ko) 2014-04-28
DK2022788T3 (da) 2010-12-13
AU2007268771A1 (en) 2007-12-06
ATE479666T1 (de) 2010-09-15
CA2652939C (en) 2014-12-02
IL195416A (en) 2012-07-31
NO20084632L (no) 2008-12-12
US7977492B2 (en) 2011-07-12
RS51517B (en) 2011-06-30
IL195416A0 (en) 2009-08-03
RU2429233C2 (ru) 2011-09-20
ES2351065T3 (es) 2011-01-31
NZ573034A (en) 2010-08-27
AU2007268771B2 (en) 2011-12-01
CN101454298A (zh) 2009-06-10
RU2008151778A (ru) 2010-07-10
PT2022788E (pt) 2010-10-04
PL2022788T3 (pl) 2011-03-31
CY1111398T1 (el) 2015-08-05
US20090275757A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
AR117778A2 (es) Forma sólida de un naftaleno carboxamida
ATE479666T1 (de) Neuer kristall von 3-ä5-ä4-(cyclopentyloxy)-2- hydroxybenzoylü-2-ä(3-hydroxy-1,2-benzisoxazol- - yl)methoxyüphenylüpropionsäure
RS54445B1 (en) 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOIL) PYRAZINE -2-CARBOXAMIDE
RS52795B (en) VINYL INDAZOLIL UNITS
RS52189B (en) 5-LIPOKSIGENAZA-ACTIVIRAJUĆEG PROTEINA (FLAP) INHIBITORIES
ATE383074T1 (de) Herbizidzusammensetzung
NZ594122A (en) 2-Phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives
JO2994B1 (ar) مثبطات البروتين الناقل لاستر الكولسترول ( cetp )
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
CY1115312T1 (el) Συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει 3-{5-[4-(κυκλοπεντυλοξυ)-2-υδροξυβενζοϋλο]-2-[(3-υδροξυ-1,2-βενζισοξαζολ-6- υλο)μεθοξυ]φαινυλο} προπιονικο οξυ ή αλας αυτου
CO6251376A2 (es) Triazolilpiridina cetonas herbicidas
TWI347947B (en) Process for preparing [4-(1,3,4-oxadiazol-2-yl)phenyl] boronic acid and use thereof
DE602007006690D1 (de) N-cyanoalkylanthranilamide als insektizide
DE502007003024D1 (de) Stempel
UA86077C2 (en) Cetp inhibitors
PE20080554A1 (es) Formulacion acuosa del acido 4-[((4-carboxibutil)-{2-[(4-fenetilbencil)oxi]fenil}amino)metil]benzoico
EP1844775A4 (de) Therapeutischer wirkstoff zur behandlung von herpes progenitalis
WO2009063901A1 (ja) クオラムセンシング阻害剤
CY2200159T2 (el) 2-ν-{5-[[4-[2-μεθυλ-2-πυριδινυλαμινο)αιθοξυ]φαινυλ]μεθυλ]-2-4-θειαζολιδινοδιονο} βουτανιοδιοϊκο οξυ, μεθοδοι παρασκευης και συνθεσεις με μηλεϊνικη ροζιγλιταζονη
CN105343970B (zh) 一种用药追踪装置及其追踪方法
DE502008000762D1 (de) Niederhalter
EA200802277A1 (ru) Контейнер для насадок к резьбозавертывающему инструменту
SE0101981D0 (sv) Pharmaceutical combination
Chen Management System of the Distributed Database Based on B/S Architecture